Sylvia Rozek, MD
Sports Medicine · Durango, CONPI 1104071588
Payments from drug & device makers
Across 34 payments — averaging $62.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$2K
- Hydrocision, Inc.$159
- Kerecis Limited$72
- Bioventus LLC$65
- Novo Nordisk$52
- Lilly USA, LLC$35
- plus $198 from 12 others
What the payments were for
- Travel & lodging$1,12953%
- Food & beverage$98147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 10 | $1,528 |
| Hydrocision, Inc. | 3 | $159 |
| Kerecis Limited | 1 | $72 |
| Bioventus LLC | 3 | $65 |
| Novo Nordisk | 3 | $52 |
| Lilly USA, LLC | 2 | $35 |
| Avanos Medical | 1 | $23 |
| Amgen | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Organogenesis Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
How this compares
$2,110 in reported general payments places this provider in the 40th percentile of 196 sports medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 426 | $89,936 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 256 | $77,058 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 170 | $50,443 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 174 | $11,325 |
| TwinrixHepatitis A And B Vaccine/Pf | 12 | $1,705 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $178 |
| Methylprednisolone | 17 | $113 |
| Meloxicam | 38 | $101 |
| Tramadol Hcl | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Durango
- Peter MillettVail$22.2M
- Matthew ProvencherVail$4.2M
- Rachel FrankAurora$1.8M
- Alan NgDenver$1.6M
- David WeinsteinColorado Springs$1.5M
- Christopher JonesColorado Springs$1.2M
- James GenuarioParker$751K
- David SchneiderGolden$746K
- Randall ViolaVail$551K
- Jonathan BravmanAurora$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.